Health Canada has granted approval for GlaxoSmithKline’s (GSK) Ojjaara (momelotinib) for treating myelofibrosis (MF) in adults with moderate-to-severe anaemia. The once-daily, oral treatment is ...
Hosted on MSN1mon
GSK's belantamab mafodotin reduced death risk by 42% in studyGSK (NYSE:GSK) reported that a study showed its ... China, United Kingdom, Canada and Switzerland.
“We believe in giving our employees the support and resources they need to excel,” says Sridhar Venkatesh, president and general manager, GSK Canada. “Our commitment to enabling talented ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback